AdvisorShares Pure US Cannabis ETF
$-0.36 (-3.27%) Today
52 Week High
52 Week Low
7 Days Mentions
“A new Gallup poll found that 68 percent of Americans support legalizing marijuana—including majorities of Republicans, Democrats and independents.” With public support at an all-time high and a Republican bill forthcoming, is the US government close to legalizing 🪴? $MSOS
“A new Gallup poll found that 68 percent of Americans support legalizing marijuana—including majorities of Republicans, Democrats and independents.” With public support swelling and a Republican bill forthcoming, is the US government close to legalizing cannabis? $MSOS
Just gonna keep DCA into MSOS by selling puts slightly OTM every time it dips. Recommend others sell puts as well unless you're confident this is the bottom for some reason. My two July 15 $13P sells that I got 85c each for aren't looking pretty now but at least I sold the puts instead of buying the 13.50 "dip" in May.
It’s definitely rigged - they suffocated buy pressure and gave HF / banks free reign to short it, accelerating returns by leveraging MSOS options. They know most institutions can’t buy, so the only action is the machines they own that short and the idiot insiders that received shares from all the M&A that just want to convert to cash and don’t know shit about equity valuation.
Could be. MSOS hasn't bought any Cresco in forever. Although, having said that, MSOS is underweight on Cresco even including the soon to be absorbed Columbia Care position. MSOS just never seemed to like them. Maybe Cresco needs to hire Todd H as an "advisor" to get Cresco back in favor with MSOS weighting (which sounds hella dirty, but it's the world we live in right now). I have noticed that with the Columbia Care acquisition, CC hasn't dropped nearly as harshly. So it's likely that CL is dropping to meet CC to close the arb gap, instead of CC going up.
Looks like they are closing the position and opening another one. This is the 3rd roll. The second position was MSOS July 1 11.50 PUT was opened at 0.75 - Today it was closed at 0.40 They either sold to open and are capturing Theta for profit, or they bought to open and closed at a loss. The newest position looks like a STO (Sell to open) with the price between 0.90-0.82. I know both MJJ and Charles of Ninepoint Alternative Health Fund will use options so this could be them.
Yo you motherfuckers think this is funny? That I pulled out? Most of my money pretty close to the top? To be honest I do still hold some small positions in some absolute ape shit. I have some VLDR $3K@15, MVST2.6K@$18.87, CLOV@21.78 smh, TDOC about $1K @ 102...smfh. Holee. But the grand finale is....MSOS $3.4K @ 50 ahahahahha. I WILL HOLD ALL OF THESE TO 0 bc you know i hate money. Although I made a fucking killing on the interest decision last week. ​ Did I mention my brother blew his fucking brains out last week as well? Shit has me fucked me up he had a 4, 7 and 10 year old and wifey. Fuuuuccckk. Did you also know that most suicidal people once they have the motivation make the decision within 5-15 minutes or they don't do it? I read this after the fact and didn't realize it was almost always an impulsive decision. Unbelievable. Buying options can also be impulsive. Put that in your pipe and smoke it.
Sorry but I can't accept this. US cannabis peaked in February 2022 and started tanking. IWM was still setting new highs 9 MONTHS LATER ! While IWM was setting new highs, MSOS was down OVER 50% How is that the same? Also your comparison to Netflix makes no sense. Netflix has an insane valuation and they were bleeding subscribers. US Cannabis is the exact opposite. Sales were growing and the valuation were cheap compared to almost every other growth stock.
It looks like somone closed their 9.9k put position exp July 1 They opened it at 1.09 on June 14th and closed it today at 1.45. It if was a buy and a sell thats 33% gain. Also someone today opened 13.86k contracts on July 1 11.5 strike MSOS at 1.45$
"The number of people with medical cannabis licenses in the U.S. rose to 2.97 million in 2020 from 678,408 in 2016, according to a study of state data published this week in the Annals of Internal Medicine. The most common qualifying condition reported by patients in 2020 was chronic pain (60.6%), with posttraumatic stress disorder (10.6%) a distant second. ....The AdvisorShares Pure US Cannabis ETF (MSOS) rose 0.3% on Friday, but is down 53.7% so far this year." ​ Something doesn't add up does it? lol The cannabis industry is crushing it right now and all of the MJ stocks are tanking, consistently like a staircase downward. But I am still accumulating shares... One day man, one sweet day
By the looks of things, you will either get in too early or too late. Starting July I'm going to buy 200 shares of MSOS every 2 weeks until I get 1000 and start selling CCs. I hope I can get those shares at $10 average or less.
I know, that drives me crazy. “Well look at SPY - everything is down!” No mention of SPY from 3/21 to 12/21, though. Go figure. If you look at a 2 year chart, SPY is up 7%. MSOS is down 52%. Not really sure what else can be said on this one…
One day in the market is meaningless. MSOS, down 56% ytd. Pltr down 53% lcid down 56% tsla down 40%, fucking FORD down 47%, nvda down 45% and down 44% I mean??? SHOP down 76% ytd, pypl down 63% nflx down 71% its a complete bloodbath fucking everywhere.
By this years' "sell in may" MSOS had already fallen 60% from its February 2021 high, so this was by no means a direct cause of the price action. Growth started selling off first, and IWM became choppy as soon as cannabis peaked, which in hindsight was the first symptom of the ongoing broader bear. I could of course be wrong and appreciate listening to others' viewpoints. Thanks for the discussion
Months ago I sold over half my stocks because of unstable income. Held onto BTC, been DCAing since 40k over the past couple months, and recently bought INTC, NVDA, and SPYV/SPYD. Plan to put some more into MSOS as well. I toyed with some other cryptos, and still earn small amounts of PRE and BAT using their web services, but these days I only buy BTC.
I had a theory about why Green Thumb was taking a hit… I thought MSOS was selling it over the last month. I was wrong. MSOS has been buying it! I’ve been collecting daily holdings of MSOS for the last 8 months. MSOS has not increased its holdings of truelieve in the last month. If I had to guess, some whale has been dumping green thumb into low liquidity and putting it into truelieve.
About 60% in NIO and rest some weed stocks like MSOS, TLRY, and my OG weed pick HEXO (-99%) and I also have some 250+ VUG calls that I bought ITM (as "safe" investments) but are now basically worthless... The weedstocks I will most likely sell on January 1st for tax purposes. NIO I will hold for about 8 more years. One lesson I learned with HEXO is that I'm great at holding a stock forever under absolutely any circumstance. Had 50k in that company and it has been the most mismanaged corporate piggy bank I've ever seen. Maybe they'll turn things around, but I highly doubt it... At this point I've literally held it to $0. So I've decided when I buy something, the only way I sell is if goes to $0 or I've held for at least 5 years.
I’m in a similar ballpark - wouldn’t have cared much if I didn’t dabble in options. I’ve only loaded up on MSOS stocks since and been fairly selective with them. Going to be a long haul, but we’ll recover a lot of it and more on the next cycle. DCAing at current levels to lower my cost basis, but learned my lesson that anything is possible, so half is going into VTI. Stim isn’t coming to bail out the market anytime soon. Find something else to look at for a few years, maybe focus on professional development to increase salary etc. This hurts for sure
Yep. For at least 6 months, the constant theme has been “you’d be crazy to sell here!”. Yet here we are, with MSOS heading towards single digits. (And single digits will absolutely happen when it’s official that SAFE will be stripped from Competes Bill).
Fuck both political parties, but if you dont think politics has a huge effect on markets you are crazy. I made bank off my prediction that dems would win the GA senate runoff election in january 2020. Non-partisan opinionated political analysis has a place here IMO. Positions: long $MSOS
Paywall: Only a few months after Dutchie raised $350 million at a mouthwatering $3.75 billion valuation, a broker started reaching out to cannabis investors with a deal—buy a multi-million-dollar stake in the cannabis software company at up to a 30% discount. In April, multiple investors across the cannabis industry got an even sweeter offering: Invest in Dutchie at a $1.7 billion implied valuation. The cannabis industry’s most valuable software company—the privately held, Bend, Oregon-based Dutchie sells e-commerce and point-of-sale software to dispensaries to help manage online orders, inventory and state law compliance—has been humbled less than a year after it raised two back-to-back rounds totaling $550 million from big names such as Tiger Global (which has backed Peloton, Roblox, Spotify and Juul), billionaire Daniel Sundheim’s D1 Capital Partners, and earlier rounds from Snoop Dogg’s Casa Verde Capital, Josh Kushner’s Thrive Capital, NBA star Kevin Durant’s fund and billionaire Starbucks CEO Howard Schultz. Dutchie “has come down to earth,” says a cannabis investment fund manager who does not invest in the company. On Monday, Dutchie laid off 8% of its 700-person workforce, citing a “dramatic market shift” and a decision to “restructure” certain parts of the organization, cofounder and CEO Ross Lipson says. GeekWire first reported the news of the layoffs. But the company’s head count is not the only thing potentially getting smaller. According to interviews with past and present employees, current Dutchie investors and fund managers who have not invested in the company, the days of its stratospheric valuation are over. (All nine people interviewed for this article would only speak on the condition of anonymity.) “Everyone knows the valuation from last year was lunacy,” says one investor who has been approached multiple times by Dutchie shareholders. “The people who paid for it in 2021 were living in a different world, a different time.” No sale on the secondary market at a lower valuation has been completed, but according to several sources, there are shareholders from every category—early employees, big and small investors—looking to exit. Some who got in early are willing to part with their shares at a sub-$1 billion implied valuation, while newer investors are hoping to cash out as low as $1.7 billion, a 55% discount from the company’s valuation in October. What drew investors to the company in the first place is the potential of the cannabis industry while it’s still in its infancy. In 2020, U.S. cannabis sales hit $17.5 billion, but that number is projected to grow to $100 billion by 2030. So Dutchie has become a way to invest in the industry without investing in a cannabis company. Dutchie, Lipson has said, will never grow, sell or distribute marijuana. Lipson says despite the layoffs, Dutchie’s position in the market is still intact and the company is delivering for its customers and investors. He also balks at the notion that Dutchie’s valuation has decreased. “Our company’s valuation has not changed since our latest financing round and any claims to the contrary are completely false,” he says. “Dutchie is in a strong position, and we are focused on continued growth. We will continue to hire top talent and pursue growth opportunities that map to our business objectives in order to advance our mission to provide safe and easy access to cannabis while helping to drive the cannabis industry forward.” Ross and his brother Zach founded Dutchie in 2017. Ross, who had sold an online food ordering business he started in college a few years prior, was waiting for an hour to buy weed from a dispensary in Bend on the first day of legalization when he had his “aha moment”—there should be a way to order cannabis online. Dutchie was born. Forbes estimates that Dutchie brought in $45 million in revenue last year, meaning it was valued at more than 80 times its revenues. By comparison, some of the best-performing software companies are valued at 20 times revenue. The head of a venture capital firm that started investing in Dutchie in 2020 and continued to invest in three consecutive rounds says they are still confident in the company but admits that it is no longer valued at $3.75 billion. He is encouraging Dutchie to “batten down the hatches” and reduce head count. “Unfortunately, despite them being fundamentally sound, you cannot ignore that tech has cratered and Dutchie definitely pushed the envelope in their Series D,” the investor says. “Am I surprised that there are offers on the secondary market? Absolutely not. Am I surprised by a 50% discount? Tech on average is down 45%, or more, and this is more speculative.” As for how an unprofitable software company with an estimated monthly burn rate of around $20 million and some $45 million in annual revenue could attain a $3.75 billion valuation in the first place, the investor points to big names like Schultz and Durant. “They couldn’t have garnered such a big number without those poster board names,” he says. Dutchie is not alone in the downturn. Akerna, another software firm and Eaze, a cannabis delivery company, also announced layoffs recently. Meanwhile, the publicly traded cannabis companies have also taken a beating: MSOS, a cannabis ETF, is down nearly 70% compared to 2021, while Curaleaf, Green Thumb Industries and Trulieve, some of the country’s largest cannabis companies, have seen their stock prices crater 60% since last June. There’s trouble across the broader venture market, too. Forbes reported last month that most startups valued at $1 billion or more are trading on the secondary markets at 20% to 40% discounts. Tiger Global declined to comment while D1 Capital and Casa Verde did not respond to calls and emails. Dutchie told Forbes that one of its current investors bought shares on the secondary market at the valuation set in October, but it wouldn’t say which one. Thrive Capital partner Gaurav Ahuja says the firm is long on Dutchie and doesn’t think economic headwinds affect the company. “The legalization of cannabis continues to spread across the world,” says Ahuja. “The industry—like Dutchie itself—is experiencing rapid growth in the face of broader macroeconomic conditions. In recent weeks, shares were purchased at Dutchie’s most recent valuation of $3.75 billion.” But one current employee and a former employee say that the company is behind in product launches, most notably Dutchie Pay, a mobile payment product that allows customers to order pot online and pay through an ACH transfer, which company leadership has said is a key to profitability. Dutchie Pay launched in alpha during the first quarter and will have a wider rollout by this summer. “People internally see the writing on the wall,” says a former employee, who was part of the recent layoffs. “Dutchie doesn’t have the products to back up its valuation—and it doesn’t have the strategy, either.” In an interview with Lipson in January, he noted that Dutchie’s business model is “nearly identical” to Shopify, the leading e-commerce platform that has seen its stock plummet more than 70% this year, while its market capitalization dropped $136 billion in the same period. An investor who declined to invest in Dutchie when multiple offers hit his desk this year, says Dutchie has a slick software offering, but wonders if it’s better than mainstream competitors. “The concept they sell people on is that they are Shopify of cannabis,” he says, “but why wouldn’t Shopify be the Shopify of cannabis?”
My prediction from 2 months ago seems to be mostly accurate. I was predicting levels of $3 for CGC, and $2 for TLRY. I might have to issue another downgrade with general market seeing even more weakness than expected. No point in rating MSO’s as they are on garbage exchanges but I will still say that we can see MSOS near $10 with worsening market conditions.